Moreover, elevated IL-13Rα2 expression correlated with decreased survival rates in glioblastoma [15] and renal cell carcinoma patients [16] and a high risk of brain metastasis from breast cancer [17]. Here, IL13RA2 is linked to hereditary clear cell renal cell carcinoma.